IMPROVED PREDICTABILITY OF EXTRACAPSULAR EXTENSION AND SEMINAL-VESICLE INVOLVEMENT BASED ON CLINICAL AND BIOPSY FINDINGS IN PROSTATE-CANCERIN JAPANESE MEN
S. Egawa et al., IMPROVED PREDICTABILITY OF EXTRACAPSULAR EXTENSION AND SEMINAL-VESICLE INVOLVEMENT BASED ON CLINICAL AND BIOPSY FINDINGS IN PROSTATE-CANCERIN JAPANESE MEN, Urology, 52(3), 1998, pp. 433-440
Objectives. The accurate preoperative prediction of the extent of canc
er by pathologic examination is essential for choosing the optimal tre
atment for patients with prostate cancer. Currently available clinical
staging methods are not adequate and more precise staging is required
. Methods. Using the log likelihood ratio test and receiver operating
characteristic (ROC) curve analysis, preoperative variables, including
biopsy pathologic findings, were assessed for predicting final pathol
ogic stage in prostate cancer. A multivariate model for predicting dis
ease organ confinement status was established for easy clinical use. R
esults. The use of the number of cores with cancer and maximum cancer
length in conjunction with the three variables (prostate-specific anti
gen, clinical stage, and biopsy Gleason score) was found to significan
tly improve predictability of extracapsular extension and seminal vesi
cle involvement in clinically resectable (n = 96) and localized prosta
te cancers (n = 81) (P <0.05). Areas under ROC curves for the above tw
o parameter sets (five- versus three-variable model) were 0.8395 and 0
.7109, respectively, for capacity for extracapsular extension predicti
on in clinically localized cancer. These values for seminal vesicle in
volvement were 0.7861 and 0.6927, respectively. The logistic model gav
e positive and negative predictive Values of 73% and 78%, and 64% and
83%, respectively, for extracapsular extension and seminal vesicle inv
olvement in clinically localized cancer at a predicted probability of
0.5 or greater. Conclusions. The present method may be used to predict
non-organ-confined prostate cancer with greater accuracy than the pre
viously reported model using three variables. UROLOGY 52: 433-440, 199
8. (C) 1998, Elsevier Science Inc. All rights reserved.